742066
Last Update Posted: 2011-03-17
Recruiting status is unknown
All Genders accepted | 18 Years-60 Years |
32 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Role of AT1-receptor Blockers in Insulin-induced Vasodilation.
In this study we hypothesize that blocking the angiotensin II AT1-receptor improves the insulin-induced microvascular dilatation. Objectives: 1. Does blockade of the angiotensin II AT1-receptor improve the insulin-induced microvascular effects in hypertensive patients. 2. Does blockade of the angiotensin II AT1-receptor impair the insulin-induced microvascular effects in normotensive control subjects?
Eligibility
Relevant conditions:
Hypertension
Insulin Resistance
Microcirculation
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov